These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3178249)
1. Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial. Fine JD; Johnson L Arch Dermatol; 1988 Nov; 124(11):1669-72. PubMed ID: 3178249 [TBL] [Abstract][Full Text] [Related]
2. General dermatologic use of hydroxamic acid. Solano E Clin Ther; 1980; 3(4):229-33. PubMed ID: 7273060 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa. Fine JD; Johnson L Arch Dermatol; 1988 Sep; 124(9):1402-6. PubMed ID: 3415285 [TBL] [Abstract][Full Text] [Related]
4. [Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester]. Vakilzadeh F; Macher E ZFA (Stuttgart); 1983 Nov; 59(33):1888-91. PubMed ID: 6362257 [No Abstract] [Full Text] [Related]
5. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group. Caldwell-Brown D; Stern RS; Lin AN; Carter DM N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407 [TBL] [Abstract][Full Text] [Related]
6. Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial. Weiner M; Stein A; Cash S; de Leoz J; Fine JD Br J Dermatol; 2004 Mar; 150(3):613-4. PubMed ID: 15030362 [No Abstract] [Full Text] [Related]
7. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial. Wolf-Jürgensen P Curr Med Res Opin; 1979; 5(10):779-84. PubMed ID: 373992 [TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa in Finland. Clinical features, morphology and relation to collagen metabolism. Kero M Acta Derm Venereol Suppl (Stockh); 1984; 110():1-51. PubMed ID: 6331034 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa. Langan SM; Williams HC Clin Exp Dermatol; 2009 Jan; 34(1):20-5. PubMed ID: 18828848 [TBL] [Abstract][Full Text] [Related]
11. [Contact allergies caused by bufexamac]. Geier J; Fuchs T Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial. Christiansen JV; Gadborg E; Kleiter I; Ludvigsen K; Meier CH; Norholm A; Reiter H; Reymann F; Raaschou-Nielsen W; Sondergaard M; Unna P; Wehnert R Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE; J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183 [TBL] [Abstract][Full Text] [Related]
16. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY; J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504 [TBL] [Abstract][Full Text] [Related]
17. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J; Sittl R Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related]
19. Dental caries risk in hereditary epidermolysis bullosa. Wright JT; Fine JD; Johnson L Pediatr Dent; 1994; 16(6):427-32. PubMed ID: 7854950 [TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]